Sex, gut microbiome, and cardiovascular disease risk

Alexander C. Razavi,
Kaitlin S. Potts,
Tanika N. Kelly and
Lydia A. BazzanoEmail author

Biology of Sex Differences201910:29

https://doi.org/10.1186/s13293-019-0240-z

Received: 31 January 2019
Accepted: 13 May 2019
Published: 10 June 2019

Abstract

Key differences exist between men and women in the determinants and manifestations of cardiovascular and cardiometabolic diseases. Recently, gut microbiome-host relations have been implicated in cardiovascular disease and associated metabolic conditions; therefore, gut microbiota may be key mediators or modulators driving the observed sexual dimorphism in disease onset and progression. While current evidence regarding pure physiological sex differences in gut microbiome composition is modest, robust research suggests that gut microbiome-dependent metabolites may interact with important biological pathways under sex hormone control, including toll-like receptor and flavin monooxygenase signaling. Here, we review key sex differences in gut microbiome interactions with four primary determinants of cardiovascular disease, impaired glucose regulation, dyslipidemia, hypertension, and obesity. Through this process, we propose important sex differences in downstream metabolic pathways that may be at the interface of the gut microbiome and cardiovascular disease.